Literature DB >> 35562242

Nutrition interventions in congenital disorders of glycosylation.

Suzanne W Boyer1, Christin Johnsen1, Eva Morava2.   

Abstract

Congenital disorders of glycosylation (CDG) are a group of more than 160 inborn errors of metabolism affecting multiple pathways of protein and lipid glycosylation. Patients present with a wide range of symptoms and therapies are only available for very few subtypes. Specific nutritional treatment options for certain CDG types include oral supplementation of monosaccharide sugars, manganese, uridine, or pyridoxine. Additional management includes specific diets (i.e., complex carbohydrate or ketogenic diet), iron supplementation, and albumin infusions. We review the dietary management in CDG with a focus on two subgroups: N-linked glycosylation defects and GPI-anchor disorders.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GPI-anchor disorder; N-linked CDG; hypoglycemia; manganese; monosaccharide therapy; pyridoxine

Mesh:

Year:  2022        PMID: 35562242      PMCID: PMC9375550          DOI: 10.1016/j.molmed.2022.04.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   15.272


  89 in total

1.  Fucose supplementation in leukocyte adhesion deficiency type II.

Authors:  A Etzioni; M Tonetti
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

2.  Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder?

Authors:  Miles D Thompson; Annie Killoran; Maire E Percy; Marjan Nezarati; David E C Cole; Paul A Hwang
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

3.  The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter.

Authors:  K Lühn; M K Wild; M Eckhardt; R Gerardy-Schahn; D Vestweber
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

4.  Cerebral and portal vein thrombosis, macrocephaly and atypical absence seizures in Glycosylphosphatidyl inositol deficiency due to a PIGM promoter mutation.

Authors:  Ben Pode-Shakked; Gali Heimer; Thierry Vilboux; Dina Marek-Yagel; Bruria Ben-Zeev; Mariska Davids; Carlos R Ferreira; Amit Mary Philosoph; Alvit Veber; Naomi Pode-Shakked; Gili Kenet; Michalle Soudack; Chen Hoffmann; Helly Vernitsky; Marina Safaniev; Maya Lodzki; Avishay Lahad; Dror S Shouval; Dana Levinkopf; Batia Weiss; Assaf Arie Barg; Ayman Daka; Ninette Amariglio; May Christine V Malicdan; William A Gahl; Yair Anikster
Journal:  Mol Genet Metab       Date:  2019-08-14       Impact factor: 4.797

Review 5.  Global view of human protein glycosylation pathways and functions.

Authors:  Katrine T Schjoldager; Yoshiki Narimatsu; Hiren J Joshi; Henrik Clausen
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-21       Impact factor: 94.444

6.  Thrombotic complications in patients with PMM2-CDG.

Authors:  M Linssen; M Mohamed; R A Wevers; D J Lefeber; E Morava
Journal:  Mol Genet Metab       Date:  2013-02-16       Impact factor: 4.797

7.  Ketogenic diet - A novel treatment for early epileptic encephalopathy due to PIGA deficiency.

Authors:  Charuta Joshi; Diana L Kolbe; M Adela Mansilla; Sara Mason; Richard J H Smith; Colleen A Campbell
Journal:  Brain Dev       Date:  2016-04-25       Impact factor: 1.961

8.  An international classification of inherited metabolic disorders (ICIMD).

Authors:  Carlos R Ferreira; Shamima Rahman; Markus Keller; Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2021-01       Impact factor: 4.750

9.  Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.

Authors:  Anna Bogdańska; Patryk Lipiński; Paulina Szymańska-Rożek; Aleksandra Jezela-Stanek; Dariusz Rokicki; Piotr Socha; Anna Tylki-Szymańska
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

10.  A Patient With CAD Deficiency Responsive to Uridine and Literature Review.

Authors:  Ling Zhou; Han Xu; Tianshuang Wang; Ye Wu
Journal:  Front Neurol       Date:  2020-02-05       Impact factor: 4.003

View more
  2 in total

Review 1.  Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG).

Authors:  Sandra Brasil; Mariateresa Allocca; Salvador C M Magrinho; Inês Santos; Madalena Raposo; Rita Francisco; Carlota Pascoal; Tiago Martins; Paula A Videira; Florbela Pereira; Giuseppina Andreotti; Jaak Jaeken; Kristin A Kantautas; Ethan O Perlstein; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

2.  A Dpagt1 Missense Variant Causes Degenerative Retinopathy without Myasthenic Syndrome in Mice.

Authors:  Lillian F Hyde; Yang Kong; Lihong Zhao; Sriganesh Ramachandra Rao; Jieping Wang; Lisa Stone; Andrew Njaa; Gayle B Collin; Mark P Krebs; Bo Chang; Steven J Fliesler; Patsy M Nishina; Jürgen K Naggert
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.